webinar register page

Webinar banner
Sight Loss and Your Genome webinar
In collaboration with the Macular Society, Retina UK and the Royal National Institute of Blind People, Genomics England is hosting a webinar series focused on sight loss and genomic research.

This webinar series aims to create a forum for the sight loss community and researchers, raising awareness of the latest scientific developments and shaping the direction of future research initiatives through patient-researcher dialogues.

At our second Sight Loss and Your Genome webinar, 5:30-6:30pm, Thursday 27th January, Vivienne Parry will be talking to Professor Mariya Moosajee and Professor Jamie Ellingford on the latest genomic research on arresting or reversing sight loss.

Jan 27, 2022 05:30 PM in London

* Required information
Loading

Speakers

Professor Mariya Moosajee
Professor Mariya Moosajee is a clinician scientist, she is a Consultant Ophthalmologist in Genetic Eye Disease at Moorfields Eye Hospital and Great Ormond Street Hospital for Children, Professor of Molecular Ophthalmology at UCL Institute of Ophthalmology, and Group Leader of Ocular Genomics and Therapeutics at the Francis Crick Institute in London. She graduated with First Class Honours in Biochemistry and Molecular Genetics in 2000, Medicine (MBBS) in 2003, and was awarded her PhD in Molecular Ophthalmology in 2009 all from Imperial College London. She has been awarded over 30 international and national prizes for her research and has over 100 peer-reviewed scientific publications. She has been named in top 100 most influential female figures in ophthalmology in The Ophthalmologist Power List 2021 and in the top 10 Champions for Change in The Ophthalmologist Power List 2019.
Dr Jamie Ellingford
Jamie is a research fellow at the University of Manchester, and based at the Manchester Centre for Genomic Medicine. Jamie’s work develops and uses computational tools to study the human genome, and tries to understand how genetic changes/differences between individuals impact the way that genes are switched on. These processes are vital for the normal function of cells, tissues and organs, and disruption can lead or contribute towards genetic conditions including those impacting vision. Jamie’s work has a primary focus of genetic disorders that are caused by disruption of cells at the back of eye, in a specialized tissue called the retina. Jamie’s work is closely aligned to the application of new technologies and software in healthcare genomics. Through increasing our understanding of the types of genetic changes that cause rare genetic disorders, we are able to help advance diagnostic testing strategies, and develop new avenues for treatment.